PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, supplying promising advancements throughout many medical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, more trusted option for therapeutic use, notably in drug